Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
31
INRLF Quote, Financials, Valuation and Earnings
Last price:
$4.20
Seasonality move
:
7.26%
Day range:
$4.20 - $4.20
52-week range:
$1.88 - $6.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.50x
P/B ratio:
4.08x
Volume:
2K
Avg. volume:
540
1-year change:
111.06%
Market cap:
$721.7M
Revenue:
$183.4M
EPS (TTM):
-$0.69
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Valneva SE has -- downside to fair value with a price target of -- per share.
INRLF vs. S&P 500
-
Over the past 5 trading days, Valneva SE has underperformed the S&P 500 by -0.2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Valneva SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Valneva SE revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Valneva SE reported revenues of $34.4M.
Earnings Growth
-
Valneva SE earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Valneva SE reported earnings per share of -$0.30.
Enterprise value:
783.3M
EV / Invested capital:
1.92x
Price / LTM sales:
3.50x
EV / EBIT:
38.58x
EV / Revenue:
3.97x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-20.46x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
38.58x
Gross Profit (TTM):
$88.9M
Return On Assets:
-21.08%
Net Income Margin (TTM):
-57.8%
Return On Equity:
-56.21%
Return On Invested Capital:
-26.5%
Operating Margin:
-137.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $234.8M | $171.9M | $197.5M | $50.3M | $34.4M | |
| Gross Profit | $29.5M | $66.4M | $88.9M | $22.1M | $6.4M | |
| Operating Income | -$142.7M | -$109.3M | -$99.5M | -$23M | -$47.4M | |
| EBITDA | -$106.1M | $23.2M | -- | -- | -$41.1M | |
| Diluted EPS | -$0.87 | -$0.04 | -$0.69 | -$0.06 | -$0.30 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $466.8M | $339.5M | $338.8M | $315.3M | |
| Total Assets | -- | $683.9M | $551.1M | $576.6M | $526.7M | |
| Current Liabilities | -- | $366.6M | $231M | $121.8M | $176.8M | |
| Total Liabilities | -- | $522.3M | $384.3M | $333.9M | $349.9M | |
| Total Equity | -- | $161.6M | $166.8M | $242.7M | $176.8M | |
| Total Debt | -- | $146.1M | $170.1M | $202.9M | $161M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$216.7M | -$172.1M | -$38.8M | -$15.3M | -$25.5M | |
| Cash From Investing | -$12.3M | $58.7M | -$2.3M | -$17.5M | -$806.6K | |
| Cash From Financing | $136.1M | $98.9M | $25.7M | $61.4M | $5.4M | |
| Free Cash Flow | -$232.7M | -$200.5M | -$38.3M | -$32.8M | -$26.3M | |
INRLF
Sector
Market Cap
$721.7M
$27.9M
Price % of 52-Week High
66.88%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
-3.51%
-1.49%
1-Year Price Total Return
111.06%
-16.66%
Beta (5-Year)
2.132
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.24
200-day SMA
Buy
Level
$3.92
Bollinger Bands (100)
Sell
Level
4.14 - 5.22
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Sell
Level
$4.27
Relative Strength Index (RSI14)
Sell
Level
36.28
ADX Line
Sell
Level
38.52
Williams %R
Neutral
Level
-44.6809
50-day SMA
Sell
Level
$4.50
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
519.4K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.8349)
Sell
CA Score
(Annual)
Level (-2.097)
Sell
Beneish M-Score
(Annual)
Level (-2.0057)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (5.1682)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.
Stock Forecast FAQ
In the current month, INRLF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INRLF average analyst price target in the past 3 months is --.
-
Where Will Valneva SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Valneva SE share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Valneva SE?
Analysts are divided on their view about Valneva SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Valneva SE is a Sell and believe this share price will rise from its current level to --.
-
What Is Valneva SE's Price Target?
The price target for Valneva SE over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is INRLF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Valneva SE is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of INRLF?
You can purchase shares of Valneva SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Valneva SE shares.
-
What Is The Valneva SE Share Price Today?
Valneva SE was last trading at $4.20 per share. This represents the most recent stock quote for Valneva SE. Yesterday, Valneva SE closed at $4.20 per share.
-
How To Buy Valneva SE Stock Online?
In order to purchase Valneva SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get INRLF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
INRLF
Sector
P/E ratio
--
23.85x
PEG ratio
0.00x
-0.01x
P/B ratio
4.08x
1.81x
Price / LTM sales
3.50x
1.58x
Growth Metrics
INRLF
Sector
Revenue growth
-31.73%
4.62%
Earnings growth
-382.11%
10.7%
Revenue (5-year growth)
5.37%
6.5%
Earnings forecast
--
-$0.21
Profitability
INRLF
Sector
Profitability FY 2024
$68.8M
$3.6M
Return on invested capital
-26.5%
-31.87%
Return on assets
-21.08%
-28.18%
Return on equity
-56.21%
-37.63%
Earnings Date
Last Earnings Date
Aug
12
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Nov
11
Balance Sheet
INRLF
Sector
Total cash
$168.6M
$26.4M
Short term investments
--
$25.7M
Total assets
$527.9M
$76.9M
Long term debt
$161M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 24.71% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 20.67% over the past day.
Buy
69
QBTS alert for Dec 23
D-Wave Quantum, Inc. [QBTS] is up 19.65% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
